- Home
- WULF vs ACLX Comparison
WULF vs ACLX Comparison
Compare WULF & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WULF
- ACLX
- Stock Information
- Founded
- WULF 1952
- ACLX 2015
- Country
- WULF United States
- ACLX United States
- Employees
- WULF N/A
- ACLX N/A
- Industry
- WULF EDP Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- WULF Technology
- ACLX Health Care
- Exchange
- WULF Nasdaq
- ACLX Nasdaq
- Market Cap
- WULF 3.5B
- ACLX 4.1B
- IPO Year
- WULF 1995
- ACLX 2022
- Fundamental
- Price
- WULF $9.13
- ACLX $72.62
- Analyst Decision
- WULF Strong Buy
- ACLX Strong Buy
- Analyst Count
- WULF 10
- ACLX 13
- Target Price
- WULF $11.40
- ACLX $114.75
- AVG Volume (30 Days)
- WULF 66.4M
- ACLX 586.8K
- Earning Date
- WULF 08-08-2025
- ACLX 08-07-2025
- Dividend Yield
- WULF N/A
- ACLX N/A
- EPS Growth
- WULF N/A
- ACLX N/A
- EPS
- WULF N/A
- ACLX N/A
- Revenue
- WULF $144,085,000.00
- ACLX $56,979,000.00
- Revenue This Year
- WULF $48.23
- ACLX N/A
- Revenue Next Year
- WULF $96.96
- ACLX $174.18
- P/E Ratio
- WULF N/A
- ACLX N/A
- Revenue Growth
- WULF 19.82
- ACLX N/A
- 52 Week Low
- WULF $2.06
- ACLX $47.86
- 52 Week High
- WULF $10.71
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- WULF 65.34
- ACLX 57.71
- Support Level
- WULF $8.60
- ACLX $67.00
- Resistance Level
- WULF $9.82
- ACLX $70.88
- Average True Range (ATR)
- WULF 0.69
- ACLX 2.46
- MACD
- WULF -0.09
- ACLX 0.03
- Stochastic Oscillator
- WULF 25.12
- ACLX 72.66
About WULF TeraWulf Inc.
TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.